Mechanisms of the dilator action of cryptotanshinone on rat coronary artery

European Journal of Pharmacology

Volumn 578, Issue 2-3, 2008, Pages 253-260

  Lam, Francis F Y ^a   Yeung, John H K ^a   Chan, Kam M ^a   Or, Penelope M Y ^a  

^a Chinese University of Hong Kong   (Hong Kong)

Author keywords

(Salvia miltiorrhiza); Calcium channel; Coronary artery; Cryptotanshinone; Danshen

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; ALCOHOL; ATROPINE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL; CALCIUM CHLORIDE; CRYPTOTANSHINONE; FLURBIPROFEN; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL INHIBITOR; PROPRANOLOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; SEROTONIN; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL ACTIVITY; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; DRUG POTENCY; ENDOTHELIUM CELL; HERB; IC 50; ISOLATION PROCEDURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALVIA MILTIORRHIZA; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; VASODILATATION;

ADENYLATE CYCLASE; ANIMALS; BENZOFURANS; CALCIUM SIGNALING; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIUM, VASCULAR; ETHANOL; GUANYLATE CYCLASE; MALE; NITRIC OXIDE SYNTHASE; PHENANTHRENES; POTASSIUM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; SALVIA MILTIORRHIZA; SEROTONIN; SIGNAL TRANSDUCTION; SOLVENTS; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 37349093645     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.09.040     Document Type: Article

References (37)

1. Adams J.D., Wang R., Yang J., and Lien E.J. Preclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditions. Chin. Med. 1 (2006) 3
2. Cao C.M., Xia Q., Zhang X., Xu W.H., Jiang H.D., and Chen J.Z. Salvia miltiorrhiza attenuates the changes in contraction and intracellular calcium induced by anoxia and reoxygenation in rat cardiomyocytes. Life Sci. 72 (2003) 2451-2463
3. Cao E.H., Liu X.Q., Wang J.J., and Xu N.F. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic. Biol. Med. 20 (1996) 801-806
4. Chan K., Chui S.H., Wong D.Y., Ha W.Y., Chan C.L., and Wong R.N. Protective effects of danshensu from the aqueous extract of Salvia miltiorrhiza (danshen) against homocysteine-induced endothelial dysfunction. Life Sci. 75 (2004) 3157-3171
5. Chen K.J. Certain progress in the treatment of coronary heart disease with traditional medicinal plants in china. Am. J. Chin. Med. 9 (1981) 193-196
6. Cheng Y.Y., Fong S.M., and Chang H.M. Protective action of Salvia miltiorrhiza aqueous extract on chemically induced acute myocardial ischemia in rats. Zhong Xi Yi Jie He Za Zhi 10 609-11 (1990) 582
7. Fung K.P., Zeng L.H., Wu J., Wong H.N., Lee C.M., Hon P.M., Chang H.M., and Wu T.W. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sci. 52 (1993) PL239-PL244
8. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., and Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48 (1995) 184-188
9. Godfraind T., Miller R., and Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol. Rev. 38 (1986) 321-416
10. Huang Y., and Ho I.H. Separate activation of intracellular Ca2+ release, voltage-dependent and receptor-operated Ca2+ channels in the rat aorta. Chin. J. Physiol. 39 (1996) 1-8
11. Ji X., Tan B.K., Zhu Y.C., Linz W., and Zhu Y.Z. Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sci. 73 (2003) 1413-1426
12. Ji X.Y., Tan B.K., and Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 21 (2000) 1089-1094
13. Kamata K., Iizuka T., Nagai M., and Kasuya Y. Endothelium-dependent vasodilator effects of the extract from salviae miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. Gen. Pharmacol. 24 (1993) 977-981
14. Kohda H., Takeda O., Tanaka S., Yamasaki K., Yamashita A., Kurokawa T., and Ishibashi S. Isolation of inhibitors of adenylate cyclase from dan-shen, the root of Salvia miltiorrhiza. Chem. Pharm. Bull. (Tokyo) 37 (1989) 1287-1290
15. Kuang P., Tao Y., and Tian Y. Radix salviae miltiorrhizae treatment results in decreased lipid peroxidation in reperfusion injury. J. Tradit. Chin. Med. 16 (1996) 138-142
16. Lam F.F., Yeung J.H., Chan K.M., and Mei Yu Or P. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vascul Pharmacol. 46 (2007) 271-277
17. Lam F.F., Yeung J.H., and Cheung J.H. Mechanisms of the dilator action of danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J. Cardiovasc. Pharmacol. 46 (2005) 361-368
18. Lam F.F.Y., Yeung J.H.K., and Cheung J.H.Y. Pharmacological evidence for calcium channel inhibition by danshen (Salvia miltiorrhiza) on rat isolated femoral artery. J. Cardivasc. Pharmacol. 47 (2006) 139-145
19. Lam F.F., Yeung J.H., Kwan Y.W., Chan K.M., and Or P.M. Salvianolic acid B, an aqueous component of danshen (Salvia miltiorrhiza), relaxes rat coronary artery by inhibition of calcium channels. Eur. J. Pharmacol. 553 (2006) 240-245
20. Lei X.L., and Chiou G.C. Studies on cardiovascular actions of Salvia miltiorrhiza. Am. J. Chin. Med. 14 (1986) 26-32
21. Li C.P., Yung K.H., and Chiu K.W. Hypotensive action of Salvia miltiorrhiza cell culture extract. Am. J. Chin. Med. 18 (1990) 157-166
22. Lippe C., and Ardizzone C. Actions of vasopressin and isoprenaline on the ionic transport across the isolated frog skin in the presence and the absence of adenyl cyclase inhibitors MDL12330A and SQ22536. Comp. Biochem. Physiol. C. 99 (1991) 209-211
23. Liu A.H., Lin Y.H., Yang M., Sun J.H., Guo H., and Guo D.A. High-performance liquid chromatographic determination of tanshinones in the roots of Salvia miltiorrhiza and related traditional chinese medicinal preparations. J. Pharm. Pharm. Sci. 9 (2006) 1-9
24. Liu G.T., Zhang T.M., Wang B.E., and Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem. Pharmacol. 43 (1992) 147-152
25. Mosaddik M.A. In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza bunge against P388 lymphocytic leukemia cells. Phytomedicine 10 (2003) 682-685
26. Nagai M., Noguchi M., Iizuka T., Otani K., and Kamata K. Vasodilator effects of des(alpha-carboxy-3,4-dihydroxyphenethyl)lithospermic acid (8-epiblechnic acid), a derivative of lithospermic acids in salviae miltiorrhizae radix. Biol. Pharm. Bull. 19 (1996) 228-232
27. Patmore L., and Whiting R.L. Calcium entry blocking properties of tanshinone II-A sulphonate, an active principle of the antianginal extract, danshen. Br. J. Pharmacol. 75 (1982) 149P
28. Ryu S.Y., Lee C.O., and Choi S.U. In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza. Planta Med. 63 (1997) 339-342
29. Shi Z., He J., Yao T., Chang W., and Zhao M. Simultaneous determination of cryptotanshinone, tanshinone I and tanshinone IIA in traditional chinese medicinal preparations containing radix Salvia miltiorrhiza by HPLC. J. Pharm. Biomed. Anal. 37 (2005) 481-486
30. Wang N., Luo H.W., Niwa M., and Ji J. A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med. 55 (1989) 390-391
31. Wang W., Hu G.Y., and Wang Y.P. Selective modulation of L-type calcium current by magnesium lithospermate B in guinea-pig ventricular myocytes. Life Sci. 78 (2006) 2989-2997
32. Wu T.W., Zeng L.H., Fung K.P., Wu J., Pang H., Grey A.A., Weisel R.D., and Wang J.Y. Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem. Pharmacol. 46 (1993) 2327-2332
33. Xie M.Z., and Shen Z.F. Absorption, distribution, excretion and metabolism of cryptotanshinone. Yao Xue Xue Bao 18 (1983) 90-96
34. Xue M., Cui Y., Wang H.Q., Hu Z.H., and Zhang B. Reversed-phase liquid chromatographic determination of cryptotanshinone and its active metabolite in pig plasma and urine. J. Pharm. Biomed. Anal. 21 (1999) 207-213
35. Zhang J., Huang M., Guan S., Bi H.C., Pan Y., Duan W., Chan S.Y., Chen X., Hong Y.H., Bian J.S., Yang H.Y., and Zhou S. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J. Pharmacol. Exp. Ther. 317 (2006) 1285-1294
36. Zhou L., Chow M., and Zuo Z. Improved quality control method for danshen products-consideration of both hydrophilic and lipophilic active components. J. Pharm. Biomed. Anal. 41 (2006) 744-750
37. Zhou W., and Ruigrok T.J. Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am. J. Chin. Med. 18 (1990) 19-24